The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.

Détails

ID Serval
serval:BIB_156A734F2887
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
Périodique
Journal of Hepatology
Auteur⸱e⸱s
Stienstra R., Mandard S., Tan N.S., Wahli W., Trautwein C., Richardson T.A., Lichtenauer-Kaligis E., Kersten S., Müller M.
ISSN
0168-8278[print], 0168-8278[linking]
Statut éditorial
Publié
Date de publication
2007
Peer-reviewed
Oui
Volume
46
Numéro
5
Pages
869-877
Langue
anglais
Résumé
BACKGROUND/AIMS: The Peroxisome Proliferator-Activated Receptor (PPAR) alpha belongs to the superfamily of Nuclear Receptors and plays an important role in numerous cellular processes, including lipid metabolism. It is known that PPARalpha also has an anti-inflammatory effect, which is mainly achieved by down-regulating pro-inflammatory genes. The objective of this study was to further characterize the role of PPARalpha in inflammatory gene regulation in liver. RESULTS: According to Affymetrix micro-array analysis, the expression of various inflammatory genes in liver was decreased by treatment of mice with the synthetic PPARalpha agonist Wy14643 in a PPARalpha-dependent manner. In contrast, expression of Interleukin-1 receptor antagonist (IL-1ra), which was acutely stimulated by LPS treatment, was induced by PPARalpha. Up-regulation of IL-1ra by LPS was lower in PPARalpha -/- mice compared to Wt mice. Transactivation and chromatin immunoprecipitation studies identified IL-1ra as a direct positive target gene of PPARalpha with a functional PPRE present in the promoter. Up-regulation of IL-1ra by PPARalpha was conserved in human HepG2 hepatoma cells and the human monocyte/macrophage THP-1 cell line. CONCLUSIONS: In addition to down-regulating expression of pro-inflammatory genes, PPARalpha suppresses the inflammatory response by direct up-regulation of genes with anti-inflammatory properties.
Mots-clé
Animals, Anticholesteremic Agents/pharmacology, Carcinoma, Hepatocellular/genetics, Carcinoma, Hepatocellular/metabolism, Female, Gene Expression Regulation, Hepatitis/genetics, Hepatitis/metabolism, Hepatocytes/drug effects, Hepatocytes/metabolism, Humans, Hypoglycemic Agents/pharmacology, Interleukin 1 Receptor Antagonist Protein/metabolism, Liver/metabolism, Male, Mice, Mice, Knockout, PPAR alpha/metabolism, Promoter Regions, Genetic/genetics, Pyrimidines/pharmacology, RNA, Messenger/metabolism, Receptors, Interleukin-1 Type I/metabolism, Thiazolidinediones/pharmacology, Transcription Factors/metabolism, Transcription, Genetic/genetics, Transcriptional Activation/genetics, Tumor Cells, Cultured, Up-Regulation/genetics
Pubmed
Web of science
Création de la notice
24/01/2008 16:04
Dernière modification de la notice
20/08/2019 12:44
Données d'usage